Viridian Therapeutics Inc (VRDN) Implied Volatility Current

Tracking VRDN implied volatility helps you identify when options premiums on Viridian Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Viridian Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when VRDN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Viridian Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For VRDN, tracking metrics like VRDN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on VRDN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where VRDN implied volatility sits today versus where it has been. Our scanner ranks Viridian Therapeutics Inc implied volatility against its historical range, surfaces extremes in VRDN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Viridian Therapeutics Inc IV is rich or cheap — measure it, then act on it.